Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 03, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended‐Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg".